1. Jeong EH, Hong SH, Park YJ, Ji IW, Kim HS. Pharmacokinetics of methotrexate after intraamniotic injection for non-surgical treatment of unruptured ectopic pregnancy. Chungbuk Med J. 2006. 16:173–179.
2. Stovall TG, Ling FW, Smith WC, Fellcer RF, Rasco BJ, Buster JE. Methotrexate treatment of unruptured ectopic pregnancy: a report of 100 cases. Obstet Gynecol. 1991. 77:749–753.
3. Cannon L, Jesionowska H. Methotrexate treatment of tubal pregnancy. Fertil Steril. 1991. 55:1033–1038.
4. Kojima E, Abe Y, Morita M, Ito M, Hirakawa S, Momose K. The treatment of unruptured tubal pregnancy with intratubal methotrexate injection under laparoscopic control. Obstet Gynecol. 1990. 75:723–725.
5. Hung TH, Shau WY, Hsieh TT, Hsu JJ, Soong YK, Jeng CJ. Prognostic factors for an unsatisfactory primary methotrexate treatment of cervical pregnancy: a quantitative review. Hum Reprod. 1998. 13:2636–2642.
6. Kang EJ, Kim HJ, Kim MH, Cho EN, Kim HJ. Conservative treatment of cervical pregnancy with MTX followed by therapeutic curettage. Korean J Obstet Gynecol. 2001. 44:1483–1487.
7. Jeong EH, Ahn CS. Single-dose methotrexate: non-surgical treatment of unruptured ectopic pregnancy. Korean J Obstet Gynecol. 1996. 39:1485–1488.
8. Schiff E, Tsabari A, Shalev E, Mashiach S, Bustan M, Weiner E. Pharmacokinetics of methotrexate after local tubal injection for conservative treatment of ectopic pregnancy. Fertil Steril. 1992. 57:688–690.
9. Fernandez H, Lelaidier C, Bourget P, Frydman R, Ville Y. Treatment of unruptured tubal pregnancy with methotrexate: pharmacokinetic analysis of local versus intramuscular administration. Fertil Steril. 1994. 62:943–947.
10. Sin SK, Yoon TJ, Hong SH, Kim YB, Ji IW, Jeong EH, et al. Conservative treatment of viable cervical pregnancy with intra-amniotic methotrexate. Korean J Obstet Gynecol. 2001. 44:2031–2035.